Literature DB >> 9332478

Cytogenetic study of pituitary adenomas.

D Bettio1, N Rizzi, D Giardino, L Persani, F Pecori-Giraldi, M Losa, L Larizza.   

Abstract

We report the results of cytogenetic studies on 23 pituitary adenoma specimens, using both the direct and short-term tissue culture methods. The direct method was applied to all of the specimens and allowed a karyotype to be identified in 15 of the processed samples (65%). Four tumors were shown to have a hypotriploid chromosomal constitution, two of which also presented structural clonal rearrangements: an isochromosome 1q,i(1)(q10) and a der(1)t(1;3)(p22;q21) were observed in two PRL-secreting adenomas, one of which also had a telomeric association involving the short arms of chromosomes 14 and 19. Telomeric associations of the long arms of chromosomes 11, 19, and 22 were observed in a near-diploid, non-secreting tumor showing monosomy 13. One other adenoma showed trisomies 8 and 12, a finding that was confirmed by means of the FISH analysis of chromosome 8 and 12 centromeric probes in the more than 300 scored nuclei. An apparently normal chromosome constitution was observed in the remaining nine cases. Short-term cultures were set up in 21 of the 23 samples, allowing us to obtain a karyotype in 18 specimens (85%). The six tumors that could not be analyzed using the direct method showed a normal karyotype. A diploid chromosome constitution was observed in the four tumors shown to be hypotriploid by the direct method as well as in the tumor with monosomy 13. The trisomies 8 and 12 identified by the direct method in one tumor were still observed, but a clone with a normal karyotype was also found. To the best of our knowledge, this is the only report of the results of cytogenetic studies on pituitary adenomas performed using both direct preparation and short-term culture.

Entities:  

Mesh:

Year:  1997        PMID: 9332478     DOI: 10.1016/s0165-4608(96)00426-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining.

Authors:  Heng Gao; Qiping Wang; Sirong Wu; Guozhen Hui
Journal:  Med Oncol       Date:  2012-07-07       Impact factor: 3.064

2.  GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.

Authors:  A Münscher; M Schmid; W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  B-RAF mutations are a rare event in pituitary adenomas.

Authors:  I De Martino; M Fedele; D Palmieri; R Visone; P Cappabianca; A Wierinckx; J Trouillas; A Fusco
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

Review 4.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

5.  Genomic instability in pituitary adenomas.

Authors:  Janusz Szymas; Karsten Schluens; Wlodzimierz Liebert; Iver Petersen
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 6.  Genetic and Epigenetic Causes of Pituitary Adenomas.

Authors:  Mengqi Chang; Chengxian Yang; Xinjie Bao; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

7.  Cytogenetic findings in lung cancer that illuminate its biological history from adenomatous hyperplasia to bronchioalveolar carcinoma to adenocarcinoma: A case report.

Authors:  Daniela Bettio; Umberto Cariboni; Anna Venci; Marialuisa Valente; Paola Spaggiari; Marco Alloisio
Journal:  Exp Ther Med       Date:  2012-09-27       Impact factor: 2.447

8.  Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report.

Authors:  Daniela Bettio; Anna Venci; Valentina Achille; Marco Alloisio; Armando Santoro
Journal:  Exp Ther Med       Date:  2015-11-16       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.